First Eagle Investment Management’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

First Eagle Investment Management’s Portfolio BLCM Stock Details BLCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-77,525	Closed	-$10.6M	–	338
2016 Q4	$10.6M	Sell	77,525 -7,881	-9%	-$1.4M	0.03%	158
2016 Q3	$17M	Hold	85,406	–	–	0.04%	157
2016 Q2	$11.1M	Buy	85,406 +26,585	+45%	+$2.96M	0.03%	176
2016 Q1	$5.5M	Buy	58,821 +28,572	+94%	+$3.11M	0.01%	176
2015 Q4	$6.13M	Buy	30,249 +5,249	+21%	+$939K	0.02%	172
2015 Q3	$3.63M	Buy	25,000 +10,000	+67%	+$1.84M	0.01%	180
2015 Q2	$3.19M	Buy	15,000 +10,000	+200%	+$2.45M	0.01%	191
2015 Q1	$1.16M	Buy	+5,000	New	+$1.21M	﹤0.01%	225

Other funds holding BLCM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

First Eagle Investment Management's BLCM Position: Q1 2017 in Review

First Eagle Investment Management sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q1 2017, closing a stake of 77,525 shares — an estimated $10.6M sold.

First Eagle Investment Management first reported a position in BLCM in Q1 2015 and held it in 8 quarters. The position peaked at $17M in Q3 2016. 96 funds tracked by Wall St. Rank hold BLCM as of Q1 2017.

First Eagle Investment Management reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
First Eagle Investment Management sold 77,525 Bellicum Pharmaceuticals, Inc. shares in Q1 2017, an estimated $10.6M.
First Eagle Investment Management first reported a position in Bellicum Pharmaceuticals, Inc. in Q1 2015 and held it in 8 quarters.
First Eagle Investment Management's Bellicum Pharmaceuticals, Inc. position peaked at $17M in Q3 2016.
96 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q1 2017.

Based on First Eagle Investment Management's 13F filing for Q1 2017, filed 5 May 2017.